China SXT Pharmaceuticals Inc. has entered into a securities purchase agreement to issue 200,000 Ordinary Shares, generating approximately $100,000 in gross proceeds. The offering, which closed on May 12, 2025, brings the total number of issued and outstanding Ordinary Shares to 16,027,758. The shares were issued under a prospectus supplement filed with the SEC, as part of a takedown from the company's shelf registration statement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.